Advertisements

Catabasis Pharmaceuticals Inc. (CATB) Stock Quote

Detailed Quote for Catabasis Pharmaceuticals Inc. (CATB)
$ 0.91   0.04 (+4.60%) Volume: 1.03m 4:00 PM EDT 22-Jun-2018
After Hours:  $ 0.907   -0.003 (-0.33%) Volume: 31k 6:52 PM EDT 22-Jun-2018
Today 5d 1m 3m 1y more
Last Price
0.91
Change $
0.04
Change %
4.60%
Tick
  
Bid
0.90
Bid Size
1,200
Ask
0.91
Ask Size
1,000
Open
0.88
High
0.91
Low
0.8641
Prev Close
0.87
Last Trade
06/22/18
Volume
1.03m
52 Wk Hi
3.77999997
52 Wk Low
0.860099971
Market Cap
26.42m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
29,035,502
EPS (TTM)
-1.14999997
PE Ratio
N/A
Exchange
NSD
News and Media for Catabasis Pharmaceuticals Inc. (CATB)
Sector News | Topic News
News for Catabasis Pharmaceuticals Inc. (CATB)
Fri, Jun 22, 2018
4:05 PM Catabasis Pharmaceuticals Announces Closing of $42M Underwritten Public Offering - Business Wire
Wed, Jun 20, 2018
12:50 PM Midday Gainers / Losers (06/20/2018) - SeekingAlpha
9:10 AM Catabasis Pharmaceuticals Announces Pricing of $42 Million Underwritten Public Offering - Business Wire
9:08 AM Premarket Losers as of 9:05 am (6/20/2018) - SeekingAlpha
Tue, Jun 19, 2018
10:26 AM Sarepta set to pop on encouraging data on DMD gene therapy - SeekingAlpha
Mon, Jun 18, 2018
8:00 AM Catabasis Pharmaceuticals to Present at Upcoming Scientific and Advocacy Conferences - Business Wire
Wed, Jun 13, 2018
8:34 AM Catabasis launches public equity offering - SeekingAlpha
Tue, Jun 12, 2018
10:00 AM Your Daily Pharma Scoop: Secondaries Review June 4-11 - SeekingAlpha
Thu, May 10, 2018
12:48 PM Catabasis Pharmaceuticals' (CATB) CEO Jill Milne on Q1 2018 Results - Earnings Call Transcript - SeekingAlpha
11:34 AM Catabasis Pharmaceuticals: Elucidating Edasalonexent's Stellar Prospects In DMD - SeekingAlpha
8:41 AM Catabasis Pharmaceuticals 2018 Q1 - Results - Earnings Call Slides - SeekingAlpha
8:09 AM Catabasis Pharmaceuticals misses by $0.09 - SeekingAlpha
8:05 AM Catabasis Pharmaceuticals Reports First Quarter 2018 Financial Results and Reviews Business Progress - Business Wire
Wed, May 09, 2018
8:15 AM Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf - Emerging Consolidated Expectations, Analyst Ratings - GlobeNewswire
Thu, May 03, 2018
8:00 AM Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 - Business Wire
Mon, Apr 30, 2018
1:43 PM Solid Biosciences moving closer to removal of clinical hold on early-stage study of DMD candidate SGT-001; shares up 6% - SeekingAlpha
1:23 PM Capricor launches mid-stage study of DMD candidate CAP-1002; shares up 2% - SeekingAlpha
Thu, Apr 26, 2018
9:31 PM Biotech Analysis Central Pharma News: AstraZeneca's Fumble, Acadia's Nuplazid Review, Catabasis' Second Success In DMD - SeekingAlpha
9:23 AM Premarket Gainers as of 9:05 am (04/26/2018) - SeekingAlpha
Wed, Apr 25, 2018
5:00 PM Catabasis Pharmaceuticals Presents New Edasalonexent Data Showing Significantly Slowed Duchenne Muscular Dystrophy Disease Progression as Measured by MRI Through One Year of Treatment - Business Wire
More News for CATB >>

Tags for Catabasis Pharmaceuticals Inc.

Research stocks or mutual funds related to Catabasis Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to CATB. The keywords below have been associated to CATB by either user submission or electronic means.